Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1978 Aug;35(2):213–221.

Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.

S Bascoul, A Cannat, M F Huguet, A Serre
PMCID: PMC1457275  PMID: 750371

Abstract

Mouse inoculation with three different phenol-insoluble fractions extracted from Brucella melitensis (fractions 'PI', '4A' and '5') induces an acceleration of the blood clearance of i.v. inoculated live Brucella and a diminution of the rate of multiplication of the injected bacteria in the spleen. Preincubation of the challenge inoculum in immune serum or i.p. injections of immune serum confer a good specific protection to non-immunized hosts. The results observed with fractionated sera suggest that, not only antibodies, but also other serum constituents may participate in the protective activity of immune sera. This discussed in terms of the respective importance of humoral and cellular immunity to Brucella and of the choice of the best preparations for human or animal vaccination.

Full text

PDF
213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cahall D. L., Youmans G. P. Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. Infect Immun. 1975 Oct;12(4):833–840. doi: 10.1128/iai.12.4.833-840.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Keppie J., Witt K., Smith H. A purified killed Brucella abortus vaccine. Br J Exp Pathol. 1971 Aug;52(4):365–370. [PMC free article] [PubMed] [Google Scholar]
  3. Lopez-Merino A., Asselineau J., Serre A., Roux J., Bascoul S., Lacave C. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances. Infect Immun. 1976 Feb;13(2):311–321. doi: 10.1128/iai.13.2.311-321.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ralston D. J., Elberg S. S. Serum-mediated immune cellular responses to Brucella melitensis REV 1. II. Restriction of Brucella by immune sera and macrophages. J Reticuloendothel Soc. 1969 Apr;6(2):109–139. [PubMed] [Google Scholar]
  6. Rasooly G., Olitzki A. L., Sulitzeanu D. Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them. Isr J Med Sci. 1966 Sep-Oct;2(5):569–584. [PubMed] [Google Scholar]
  7. Roux J., Asselineau J., Serre A., Lacave C. Propriétés immunologiques d'un extrait phénol-insoluble de Brucella melitensis (fraction P.I.) Ann Inst Pasteur (Paris) 1967 Sep;113(3):411–423. [PubMed] [Google Scholar]
  8. Roux J., Serre A., Asselineau J., Lacave C. La vaccination humaine antibrucellique par une fraction antigénique de Brucella melitensis. Bull Acad Natl Med. 1970 Apr-May;154(15):318–322. [PubMed] [Google Scholar]
  9. SULITZEANU D. Passive protection experiments with Brucella antisera. J Hyg (Lond) 1955 Jun;53(2):133–142. doi: 10.1017/s0022172400000619. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES